Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

High Slew Rate 1.5 T MRI Designed for Advanced MR Applications

By Medimaging International staff writers
Posted on 04 Jan 2011
Certain magnetic resonance imaging (MRI) exams such as advanced cardiac and neuroimaging require a system with enhanced gradients for better image quality and quicker exams. For these applications, a new 1.5 Tesla (T) MR system has been developed with high slew rate gradients and new user interface, M-Power.

Toshiba Medical Systems (Tokyo, Japan) presented the new Vantage Titan HSR at the 2010 Radiological Society of North America (RSNA) annual meeting, held in Chicago, IL, USA, November 28-December 3, 2010.

The high slew rate (HSR) gradients (gradient strength 30 [mT/m] | slew rate 203 [mT/m/ms]) of the Titan HSR improve the capability for advanced cardiac and neurological applications as well as MR angiography (MRA) body, breast, and abdominal imaging. The new gradients improve temporal and spatial resolution and the ability for clinicians to make accurate diagnoses. The M-Power interface has many new efficiency tools as well as sophisticated postprocessing software available on the main console, enhancing department workflow. The system also features an open bore that is 18% larger than other 1.5 T systems on the market and features a large 71-cm patient aperture, excellent homogeneity, and an extremely high clinical field-of-view (FOV) of 55 cm x 55 cm x 50 cm, providing a very high level of patient care and diagnostic capability in MR imaging.

The Vantage Titan HSR is an enhancement to the Vantage Titan and therefore includes numerous patient-friendly features. The Vantage Titan HSR's patient-focused features significantly improve patient comfort and increase the range of patients who can be imaged with MR. The open bore provides a greater feeling of openness for the patient, and Toshiba's patented Pianissimo technology dramatically reduces acoustic noise, the most significant cause of patient discomfort during an MR exam. The Vantage Titan HSR also utilizes Toshiba's Atlas SPEEDER integrated coil technology to reduce exam time and improve the overall exam experience for patients. Because the coils are integrated into the table, patients do not need to be continually repositioned, which saves time and improves patient comfort. Moreover, many procedures can be performed feet first with a patient's head comfortably lying outside of the bore, considerably reducing claustrophobia.

The Vantage Titan HSR MR system also takes advantage of Toshiba's proprietary, contrast-free MRA techniques: fresh blood imaging (FBI), contrast-free improved angiography (CIA), time-spatial labeling inversion pulse (Time-SLIP) and time space angiography (TSA). Contrast-free imaging is particularly important because gadolinium, the most common contrast agent used for magnetic resonance imaging (MRI) and MRA exams, has been directly linked to a sometimes-fatal disease that occurs in patients with renal insufficiency, called nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD).

"Combining high slew rate gradients with the Vantage Titan's patient-focused features creates the premium 1.5 T MR system on the market,” said Stuart Clarkson, director, MR business unit, Toshiba. "Advanced MR applications are allowing patients to undergo safer imaging with no radiation, all while providing highly accurate information for diagnosis.”

Related Links:

Toshiba Medical Systems






RADCAL
RTI ELECTRONICS AB
SuperSonic Imagine

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.